Trial Profile
A phase I/II trial to investigate Imprime PGG (PGG glucan) in combination with monoclonal antibody (MAb) therapies in rituximab-refractory follicular lymphoma
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Odetiglucan (Primary)
- Indications Follicular lymphoma
- Focus Adverse reactions
- 20 Aug 2015 New trial record